Our focus lies on treating diseases of the cardiovascular and central nervous systems.
Click here to learn moreOne of the fundamental pillars of Egis Group’s strategy is innovation. We devoted EUR 48 million to research and development in the 2022/2023 financial year.
We have more than 90 years of experience in research and development. As for the number of Innovation Prizes granted, we are one of the most successful companies in Hungary: our generic product development activities have been awarded eight Innovation Prizes and one Innovation Grand Prize
We carry out our research and development activities at our three sites in Hungary, we have more than 500 professionals working in the field of R&D.